[Anticoagulation in the elderly--a thin line between benefit and risk].
Steffel
J
J
Klinik für Kardiologie, UniversitätsSpital Zürich und Kardiovaskuläe Forschung, Institut für Physiologie, Universität Zürich.
Lüscher
T F
TF
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D019934:International Normalized Ratio; D020766:Intracranial Embolism / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D011183:Postoperative Complications / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D012307:Risk Factors; D055502:Secondary Prevention
D000925:Anticoagulants